Objectives
• Discuss the risks associated with peripheral IV placement and dwell time.
• Describe specific recommendations for the frequency of peripheral IV site assessment based upon patient and infusate characteristics. The Problem
• Lack of specific guidelines for frequency for site assessment is a problem • Great variation in practice • Frequent assessment of the site allows for rapid action and less risk for serious tissue damage, a risk associated with the common complication of infiltration What this INS Position Paper addresses:
• Limited to recommendations on how often to assess the "short" peripheral IV (PIV) site • Does not address midline peripheral catheters • Limited to infusions (i.e. not IV push) • Recognizes that regular assessment is just one factor in reducing the risk of PIV complications but it is a critical factor in allowing quick intervention in the event of a complication • Infiltration/extravasation without rapid recognition/appropriate treatment can result in:
-Full thickness skin loss -Muscle/tendon necrosis -Permanent scarring -Loss of extremity function -Amputation -Chronic pain/neuropathy -Surgery
• Case studies -IV fluid infiltration -3 infants with tissue blanching, decreased CRT, severely restricted active/passive ROM required fasciotomies with full recovery -"the role of vigilant nursing to detect these injuries
[infiltrations] cannot be understated"
• "Infiltration/extravasation injuries are medical emergencies that have potential to cause serious disability, diminish QOL" Talbot Literature Review
• The CDC recommends at least daily evaluation of the insertion site by palpation through the dressing to discern tenderness and by inspection if a transparent dressing is used • CDC recommendations are in the context of the risk for vascular-related infections/phlebitis and does not address other peripheral IV risks.
Patient Education
• A critical factor in risk reduction • The alert and oriented patient, and/or family members/caregivers, should be provided with information about the PIV, potential risks, and instructed to promptly report signs or symptoms such as swelling, redness, pain, and/or paresthesias/numbness or tingling in the extremity.
Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2011:34(1S): S16.
• "An IV infusion should not be painful if the drug is diluted and slowly injected through a catheter that has been properly selected, inserted, and secured. Pain on injection is an immediate indication to stop. Most severe complications occur because the infusion continues while staff consider other explanations for the pain"
Hadaway, L (2007) Infiltration and extravasation: preventing a complication of IV catheterization. AJN 107 (6), 64-72.
INS POSITION PAPER
Position Paper Recommendation: WHAT to assess
• When an infusion is running (whether continuous or intermittent*), PIV sites should be routinely assessed:
-For redness, tenderness, swelling, drainage, and/or the presence of paresthesias, numbness, or tingling at the specified frequency listed below. -Assessment should include visual assessment, palpation, and subjective information from the patient. 
